News | News By Subject | News by Disease News By Date | Search News

Leukemia [Acute myelogenous leukemia (AML)] News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Seattle Genetics (SGEN) Takes Another Hit as the FDA Slaps Hold on IND for Vadastuximab Talirine     6/22/2017
GlycoMimetics (GLYC) Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag     5/18/2017
4 Fatal Deaths in Seattle Genetics (SGEN)' Early-Stage Trials of AML Drug     12/30/2016
New York’s Cellectis (ALCLS) Looks to 2017 for Clinical Trials of AML Treatment     12/16/2016
FDA Places Clinical Hold on AML Drug Co-Developed by Johnson & Johnson (JNJ) and Genmab A/S (GEN.CO)     9/20/2016
Another Celgene (CELG) Bet Pays Off as Agios (AGIO) Eyes Early Approval of Leukemia Drug     9/8/2016
FDA Berates Celator Pharma (CPXX) for Pushing Unapproved Leukemia Drug to Doctors     9/8/2016
MEI Pharma (MSHL)'s Pracinostat Called a Breakthrough By the FDA     8/1/2016
Ultragenyx (RARE) Rising on Phase III Acute Myeloid Leukemia Data     7/15/2016
Celator Pharma (CPXX) Jumps on Breakthrough Therapy Win for Lead Cancer Drug     5/19/2016
3 Biotechs Getting Another Shot After Failed Trials     4/7/2016
Celator Pharma (CPXX) Stock Jumps 400% Premarket as AML Drug Wows in Phase III Study     3/16/2016
Akinion Halts Further Development of AKN-028 Due to Safety Concerns     3/4/2016
Forty Seven Launches with Half of $75 Million Series A Backed by Google (GOOG) and 100+ Patents     2/26/2016
Novartis AG (NVS)'s Leukemia Drug Gets Breakthrough Designation, Same Week as AstraZeneca PLC (AZN) and Roche (RHHBY) Drugs     2/22/2016

News from Around the Web
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
Less Is More With Acute Myeloid Leukemia Drug, Erasmus University Medical Center Study     3/17/2011
Mutations in Single Gene Predict Poor Outcomes in Adult Leukemia; Discovery May Guide Treatment for Acute Myeloid Leukemia, Washington University Study     11/11/2010
Protein That Predicts Prognosis Of Leukemia Patients May Also Be A Therapeutic Target, Whitehead Institute and Children's Hospital Boston Reveals     7/12/2010
Umbilical Cord Best Treatment for Childhood Leukaemia     6/8/2007
Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down     3/1/2007
Researchers Develop New Strategy For The Treatment Of CML     1/18/2007
Role For Proteomics In Identifying Hematologic Malignancies     1/11/2007
Study Identifies Molecular Process Underlying Leukemia     8/22/2006
Cytoplasmic Location Of Shuttling Protein Often Seen With AML     1/20/2005
Perpetual AML Can Arise From Rare Leukemic Stem Cell     6/1/2004
Gene Expression Profiling Yields Prognostic Information For AML Patients     4/14/2004

Press Releases
Tolero Pharmaceuticals To Expand Enrollment Of Phase II Study Of Alvocidib In MCL-1-Dependent AML Into Europe     6/21/2017
Actinium (ATNM.OB) To Host Webinar On June 12th To Update On Pivotal Phase III SIERRA Clinical Trial For Iomab-B     6/12/2017
Mateon Therapeutics (MATN) Provides Update On Its Clinical Trial Programs And Milestones     6/12/2017
Mateon Therapeutics (MATN) Receives FDA Fast Track Designation For Oxi4503 In Patients With Acute Myeloid Leukemia     6/7/2017
Astellas (ALPMY) Release: Exploratory Analysis Of The Phase I/II CHRYSALIS Study Of Gilteritinib Demonstrates First Molecular Response To FLT3 Inhibitor In Acute Myeloid Leukemia     6/6/2017
Helsinn And MEI Pharma (MEIP) Report Correlation Between Mutations In DNA Methylation Pathway And Clinical Response In Phase II Study Of Pracinostat And Azacitidine In Acute Myeloid Leukemia     6/5/2017
Jazz Pharma (JAZZ) Announces FDA Acceptance Of NDA For VYXEOS (CPX-351), An Investigational Treatment For Acute Myeloid Leukemia, With Priority Review Status     6/1/2017
TrovaGene (TROV) Release: Phase l Safety Study Supports Planned Development Of PCM-075 In AML     5/25/2017
Actinium (ATNM.OB) Granted Orphan Designation From The EMA For Actimab-A     5/24/2017
Data From Clinical Study Of NewLink Genetics (NLNK)’ IDO Pathway Inhibitor, Indoximod, To Be Presented At The 22nd European Hematology Association Congress     5/18/2017
TRACON Pharma (TCON) Announces Publication In Blood Of Preclinical Data Indicating Activity Of TRC105 In Acute Myeloid Leukemia And B-Cell Acute Lymphoblastic Leukemia     5/12/2017
Preclinical Data On Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented At AACR Hematologic Malignancies Meeting     5/8/2017
Bay Area's Sunesis (SNSS) Drops After Withdrawing Leukemia Drug Application     5/2/2017
ZIOPHARM Oncology (ZIOP) Announces FDA Acceptance Of IND For CD33-Specific CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia     5/2/2017
Novartis AG (NVS) Receives FDA Approval For Rydapt In Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) And Three Types Of Systemic Mastocytosis (SM)     5/1/2017